文献速递血管炎

巨细胞动脉炎与风湿性多肌痛的全球发病率和患病率:系统文献综述

Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.
PubMed 文献 · Semin Arthritis Rheum · 2020-07-14

该系统文献综述检索了PubMed和Google Scholar至2019年7月30日的文献,纳入77篇报告巨细胞动脉炎(GCA)和/或风湿性多肌痛(PMR)发病率或患病率的研究。结果显示GCA发病率在北欧和英国最高(14.6-43.6/10万≥50岁人群),美国明尼苏达为19.8/10万,南欧较低(1.1-11.1/10万);PMR在白种人中患病率至少为GCA的3倍,但PMR流行病学数据更有限且变异更大。

要点

  • GCA发病率在北欧和英国最高,南欧较低,非白种人群中较少见。
  • 白种人中PMR患病率至少为GCA的3倍。
  • 采用严格病例验证的研究倾向于报告更低的估计值,尤其对PMR。

核心结论

  • 该综述提供了全球不同人群GCA和PMR发生率的最新估计,GCA在北欧裔人群中发病率更高,PMR流行病学数据更有限且变异更大。

研究设计与样本

  • 系统检索PubMed和Google Scholar自建库至2019年7月30日的文献,两位作者筛检2643篇摘要,最终纳入77篇报告GCA和/或PMR发病率或患病率的研究。

主要发现

  • GCA发病率在斯堪的纳维亚和英国为14.6至43.6/10万≥50岁人群,美国明尼苏达为19.8/10万,南欧为1.1至11.1/10万。
  • 有限证据表明GCA和PMR在非白种人群中较少见。
  • 白种人中PMR患病率估计至少为GCA的3倍。

关键数值与推荐

  • GCA最高发病率(每10万≥50岁人群)在斯堪的纳维亚和英国为14.6至43.6,美国明尼苏达为19.8,南欧为1.1至11.1。
  • 白种人中PMR患病率估计至少为GCA的3倍。

临床怎么用

  • 临床医生应知晓GCA和PMR的发病率存在地域和种族差异,北欧裔人群发病率更高。
  • 对于疑似PMR患者,应考虑其患病率可能高于GCA,但需注意研究间变异较大。

局限性

  • 纳入研究在研究设计和研究人群方面存在广泛变异。
  • PMR的流行病学数据比GCA更有限,发病率和患病率估计变异更大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Giant cell arteritis (GCA; sometimes referred to as temporal arteritis) and polymyalgia rheumatica (PMR) are common and interrelated inflammatory conditions that almost exclusively affect adults older than 50 years. There is a need for updated information on the epidemiology of these diseases. OBJECTIVE: This systematic literature review (SLR) aims to summarize current evidence regarding the global incidence and prevalence of GCA and PMR. METHODOLOGY: A systematic search of PubMed and Google Scholar databases from their inception dates to July 30, 2019 for relevant publications was performed. Studies that reported incidence and/or prevalence estimates for GCA and/or PMR were identified. When there were multiple studies of the same population, the most recent estimates were used. Details on source populations and case validation were systematically reviewed. Results were tabulated per region in the world. RESULTS: Screening by 2 authors resulted in 2643 abstracts, of which 77 articles met the inclusion criteria. There were more studies on GCA compared to PMR, and more on incidence than on prevalence. Wide variations were found in study design and populations studied. Studies that included a thorough case validation tended to give lower estimates, in particular for PMR. The highest incidence per 100 000 aged ≥50 years of GCA was observed in studies from Scandinavia and the UK (14.6 to 43.6), and in Minnesota, USA (19.8 per 100 000). Corresponding estimates for Southern Europe were lower (1.1 to 11.1). Limited evidence indicates that GCA and PMR is less common in non-Caucasian populations. Prevalence estimates for PMR were ≥ 3 times higher than that of GCA in Caucasians. CONCLUSION: This SLR provides up to date estimates of the occurrence of GCA and PMR in different populations around the world. The incidence of GCA is higher in populations of Northern European ancestry. Data on the epidemiology of PMR are more limited, with greater variation in incidence and prevalence estimates.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Sharma A, Mohammad AJ, Turesson C, et al. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review. Semin Arthritis Rheum. 2020. PMID: 32911281. doi:10.1016/j.semarthrit.2020.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。